Tranilast

曲尼司特

Report date: 2023/03/16 15:09:09
NME

Base Information

Drug NameTranilast
Drug Alias Name肉桂氨茴酸Tranilastum甲氧桂氨酸曲尼斯特Rizaben +[8] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionCollagen inhibitorsImmunomodulators
TargetsCollagen
Therapy Area/IndicationsEczemaConjunctivitisRhinitis, Allergic +[5] 
Global Approved IndicationsEczemaConjunctivitisRhinitis, Allergic +[4] 
Approved Indications in ChinaRhinitis, AllergicAsthma
Original Approved Country/TerritoryJapan
Original Approved Date1982/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNuon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKissei Pharmaceutical Co LtdNortheast Pharmaceutical Group Shenyang No 1 Pharmaceutical Co LtdPharmaceutical University Pharmaceutical Co Ltd
Inactive CompaniesNuon Therapeutics Inc
Active IndicationsEczemaConjunctivitisRhinitis, Allergic +[4] 
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeR
Related LinksWikipediaDrugBankKEGG